GLP-1 drugs are covered by almost all employer-sponsored health plans for the treatment of diabetes
Clinical trials show that women using PT-141 experience: Stronger baseline desire More frequent arousal Heightened satisfaction Improved ease of becoming mentally engaged A reduction in anxiety around intimacy Because the peptide bypasses hormone fluctuations, it works for women with both stable and unstable hormone levels
Clinicians can improve treatment continuation through patient education, slower dose titration when needed, early follow-up, side effect management, and support around cost and access
Consistently, compared with placebo, more participants receiving any of the three tirzepatide doses had reductions in body weight of at least 5%, 10% or 15% (ESM Table 2)
Cardiovascular disease and risk management: Standards of medical care in diabetes
We understand that everyone is different, which is why our team has a deep understanding of all aspects of our technology and how different patients require different approaches.